113 related articles for article (PubMed ID: 343497)
1. Humoral and cell-mediated immunity to hepatitis B virus antigen in a haemodialysis-renal transplantation unit.
Skinhøj P; Aldershvile J; Hardt F
Acta Pathol Microbiol Scand C; 1977 Dec; 85C(6):401-5. PubMed ID: 343497
[TBL] [Abstract][Full Text] [Related]
2. Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen-negative Patients Undergoing Kidney Transplantation.
Jeon JW; Kim SM; Cho H; Baek CH; Kim H; Shin S; Kim YH; Han DJ; Kim SB
Transplantation; 2018 Oct; 102(10):1717-1723. PubMed ID: 29621059
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B surface antigen (HBsAg) infection in a hemodialysis unit. II. Factors affecting host immune response to HBsAg.
Sengar DP; Rashid A; McLeish WA; Harris JE; Couture RA; Sutherland M
Can Med Assoc J; 1975 Nov; 113(10):945-8. PubMed ID: 1104126
[TBL] [Abstract][Full Text] [Related]
5. Humoral and cell-mediated immunity to hepatitis B virus antigens in acute and chronic liver disease.
Aldershvile J; Dietrichson O; Hardt F; Nielsen JO; Skinhöj P
Scand J Gastroenterol; 1977; 12(8):917-22. PubMed ID: 605351
[TBL] [Abstract][Full Text] [Related]
6. Concomitant hepatitis B surface antigen and antibody in thirteen patients.
Foutch PG; Carey WD; Tabor E; Cianflocco AJ; Nakamoto S; Smallwood LA; Gerety RJ
Ann Intern Med; 1983 Oct; 99(4):460-3. PubMed ID: 6625377
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of immune response in chronically hemodialysed carriers of HB, antigen.
Jagielski P; Szkaradkiewicz A; Potocka-Michajluk U
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):553-8. PubMed ID: 749808
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus markers in anti-HBc only positive individuals.
Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
[TBL] [Abstract][Full Text] [Related]
9. [Results of vaccination with the hepatitis B vaccine in patients and personnel at the Hemodialysis Center in Karlovac].
Palmović D; Vitas B; Doko A; Belavić Z; Racki L
Lijec Vjesn; 1989 Nov; 111(11):400-4. PubMed ID: 2534601
[TBL] [Abstract][Full Text] [Related]
10. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L
S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
[TBL] [Abstract][Full Text] [Related]
11. Presence and meaning of anti-HBc IgM as determined by ELISA in patients with acute type B hepatitis and healthy HBsAg carriers.
Kryger P; Mathiesen LR; Aldershville J; Nielsen JO
Hepatology; 1981; 1(3):233-7. PubMed ID: 7286902
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS).
Ogutu EO; Amayo EO; Okoth F; Lule GN
East Afr Med J; 1990 May; 67(5):355-8. PubMed ID: 2390958
[TBL] [Abstract][Full Text] [Related]
13. Isolated presence of antibody to hepatitis B core antigen in dialysis patients: occurrence of subclinical hepatitis?
Lai KN; Tam JS; Lai FM; Lin HJ
Am J Kidney Dis; 1989 May; 13(5):370-6. PubMed ID: 2497642
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus among Saudi children in Gizan, Saudi Arabia.
Parande CM; Arya SC; Ashraf SJ
Infection; 1986; 14(5):223-5. PubMed ID: 3793237
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus infections in Omani patients with renal diseases.
Aghanashinikar PN; al-Dhahry SH; al-Marhuby HA; Buhl MR; Daar AS; Al-Hasani MK
Transplant Proc; 1992 Oct; 24(5):1913-4. PubMed ID: 1412910
[TBL] [Abstract][Full Text] [Related]
16. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
17. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
18. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
[TBL] [Abstract][Full Text] [Related]
19. [Hbeag/Anti-hbe system and other markers for hepatitis b in a dialysis unit (author's transl)].
Turci F; Iosa G; Cipolloni A; Cenciotti L
Quad Sclavo Diagn; 1980 Dec; 16(4):349-55. PubMed ID: 7244108
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis A and B: serologic survey of various population groups.
Krugman S; Friedman H; Lattimer C
Am J Med Sci; 1978; 275(3):249-55. PubMed ID: 210666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
